Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - application
11
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Fluorinated MU-Opioid Receptor Agonists
Summary: Investigators at the National Institute on Drug Abuse seek co-development partners and/or licensees for collection of mu opioid receptor (MOR) agonists as alternatives for existing compounds. Description of Technology: Although existing opioids are excellent analgesics and useful as positron emission tomography (PET) radiotracers, they come...
Published: 12/20/2024
|
Inventor(s):
Michael Michaelides
,
Juan Gomez
,
Kenner Rice
,
Agnieszka Sulima
,
Michael Baumann
Keywords(s):
Category(s):
Application
,
Application
> Therapeutics
,
Collaboration Sought > Collaboration
,
TherapeuticArea > Immunology
,
TherapeuticArea > Neurology
,
TherapeuticArea > Radiology
,
Collaboration Sought > Licensing
Suppression Of Uveitis By A STAT3 Single Domain Antibody
Summary: The National Eye Institute seeks research co-development partners and/or licensees for a STAT3 antibody that can suppress uveitis. Description of Technology: Uveitis is caused by inflammation in the eye that causes pain and reduce vision in affected patients. Rates of uveitis in the United States occurs 1 in every 200 people with eye-related...
Published: 12/23/2024
|
Inventor(s):
Charles Egwuagu
,
Sunanda Singh
Keywords(s):
Category(s):
Application
,
Application
> Therapeutics
,
Collaboration Sought > Collaboration
,
TherapeuticArea > Neurology
,
TherapeuticArea > Ear, Nose, & Throat
,
Collaboration Sought > Licensing
Novel Kinase Inhibitory Thiazines
Summary The National Cancer Institute (NCI) seeks research co-development partners and/or licensees for a class of novel aplithianine-derived small molecule analogs that compete with ATP for binding on a range of clinically relevant kinases including: Oncogenic gene fusion DNAJB1-PRKACA (PKADJ) Wild type protein kinase A (PKA) Protein kinase...
Published: 12/20/2024
|
Inventor(s):
Barry O'Keefe
,
Lin Du
,
Brice Wilson
,
Ping Zhang
,
William Moore
,
Dongdong Wang
,
Juliana Martinez Fiesco
,
Ning Li
Keywords(s):
Category(s):
Application
,
Application
> Therapeutics
,
Collaboration Sought > Collaboration
,
TherapeuticArea > Oncology
,
TherapeuticArea > Rare / Neglected Diseases
,
TherapeuticArea > Infectious Disease
,
Collaboration Sought > Licensing
Improved Methods For Cryopreservation Of Cells, Tissues, And Organs
Summary: The National Eye Institute seeks research co-development partners and/or licensees for novel methods of cryopreserving cells, tissues, and organs via FOXO1 activation and other mechanisms. Description of Technology: The cornea is a critical part of the eye that helps prevent debris from entering and refracts light for proper vision. Corneal...
Published: 12/23/2024
|
Inventor(s):
Jingxing Ou
,
Kiyoharu Miyagishima
,
Guanghui Jin
,
Wei Li
,
Lihao Ge
Keywords(s):
Category(s):
Application
,
Application
> Research Materials
,
Collaboration Sought > Collaboration
,
TherapeuticArea > Ear, Nose, & Throat
,
Collaboration Sought > Licensing
TYROSINASE Gene Therapy for Oculocutaneous Albinism type 1A
Summary: The National Eye Institute seeks research co-development partners and/or licensees for an adeno-associated viral gene therapy for Oculocutaneous Albinism type 1A. Description of Technology: Oculocutaneous albinism (OCA) is a genetically heterogeneous congenital disorder characterized by decreased or absent pigmentation in the hair,...
Published: 12/23/2024
|
Inventor(s):
Brian Brooks
,
Aman George
Keywords(s):
Category(s):
Application
,
Application
> Therapeutics
,
Collaboration Sought > Collaboration
,
TherapeuticArea > Rare / Neglected Diseases
,
TherapeuticArea > Ophthalmology
,
TherapeuticArea > Ear, Nose, & Throat
,
Collaboration Sought > Licensing
Free Breathing Motion Corrected Pixel-wise MRI Myocardial T1 Parameter Mapping for Clinical Cardiac Imaging
This technology includes a method for performing cardiac imaging without the need for the patient to hold their breath. Free breathing pixel-wise myocardial T1 parameter mapping includes performing a free-breathing scan of a cardiac region at a plurality of varying saturation recovery times to acquire a k-space dataset; generating an image dataset based...
Published: 8/12/2024
|
Inventor(s):
Bruce Spottiswoode
,
Peter Kellman
Keywords(s):
Category(s):
Application
,
Application
> Medical Devices
,
Application
> Software / Apps
,
ResearchProducts > Computational models/software
,
ResearchProducts > Research Equipment
,
TherapeuticArea > Cardiology
Pigment Epithelium-Derived Factor Peptides and Use for Treating Retinal Degeneration
Summary: The National Eye Institute (NEI) seeks research co-development partners and/or licensees for the development of an eyedrop formulation and/or AVV2-based delivery system to deliver the 17-mer [H105A] peptide to treat retinal degeneration. Description of Technology: Retinitis pigmentosa (RP) is one of the most common inherited retinal...
Published: 12/23/2024
|
Inventor(s):
S. Patricia Becerra
Keywords(s):
Category(s):
Application
,
TherapeuticArea
,
Collaboration Sought > Collaboration
,
TherapeuticArea > Ear, Nose, & Throat
,
Collaboration Sought
,
Collaboration Sought > Licensing
Selective A3 Adenosine Receptor Agonists for the Treatment of Chronic Neuropathic Pain and Other Conditions
This technology includes the creation and use of A3 adenosine receptor (A3AR)-selective agonists for treating chemotherapy-induced peripheral neuropathy, chronic neuropathic pain, rheumatoid arthritis, psoriasis, and other conditions. A3 receptors for adenosine are found in most cells and endogenous activation of the A3 receptors can result in apoptosis,...
Published: 8/12/2024
|
Inventor(s):
Daniela Salvemini
,
Dilip Tosh
,
Kenneth Jacobson
Keywords(s):
Category(s):
Application
,
Application
> Therapeutics
,
Collaboration Sought > Collaboration
,
Collaboration Sought > Licensing
,
TherapeuticArea > Cardiology
,
TherapeuticArea > Dermatology
,
TherapeuticArea > Immunology
,
TherapeuticArea > Oncology
Method To Generate Chondrocytes from Human Induced Pluripotent Stem Cells (hIPSCs) and their use in Repairing Human Injury and Degenerative Diseases
This technology includes a method for differentiating human induced pluripotent stem cells (hiPSCs) into stable chondrocytes, capable of producing cartilage, and their use in cartilage repair in human injury and degenerative diseases. In suspension culture, hiPSC aggregates demonstrate gene and protein expression patterns similar to articular cartilage....
Published: 8/12/2024
|
Inventor(s):
Pamela Robey
,
Stephen Gadomski
Keywords(s):
Category(s):
Application
,
Application
> Research Materials
,
Application
> Therapeutics
,
Collaboration Sought > Licensing
,
ResearchProducts > Human iPSC Lines
,
ResearchProducts > Human Cell Lines
,
TherapeuticArea > Immunology
T Cell Receptors Targeting the KRAS G13D Mutation in the Context of HLA-A11:01 for Research Use
Summary: The National Cancer Institute (NCI) has identified HLA-A11:01-restricted T Cell Receptors (TCRs) targeting the KRAS G13D mutation. The NCI seeks licensees for the use of these TCRs in research. Description of Technology: Tumor-specific mutated proteins can create immunogenic, mutation-containing “neoepitopes” which are attractive...
Published: 12/18/2024
|
Inventor(s):
Catherine Ade
,
Zhiya Yu
,
Matthew Sporn
,
James Yang
,
Kenichi Hanada
Keywords(s):
Category(s):
TherapeuticArea
,
Application
,
Application
> Research Materials
,
Collaboration Sought > Licensing
1
2